糖皮质激素使用与首发及复发性静脉血栓栓塞风险:自身对照病例系列与队列研究
基于MEGA研究2547例VTE患者链接荷兰药品统计登记,采用自身对照病例系列法评估口服糖皮质激素暴露期间首发VTE风险,并以队列设计评估复发风险。
核心结论
- 口服糖皮质激素治疗期间首发和复发VTE风险均升高。
- VTE风险升高是药物治疗与基础疾病共同作用的结果。
- 治疗初期风险最高,6个月后风险下降但仍可能升高。
研究设计与样本
- 研究纳入MEGA研究中2547例VTE患者,链接荷兰药品统计登记。
- 采用自身对照病例系列法评估首发VTE风险,采用队列设计评估复发VTE风险。
临床怎么用
- 处方口服糖皮质激素时应评估VTE风险,尤其在治疗初期。
- 对有VTE病史者,使用糖皮质激素期间需关注复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glucocorticoid treatment increases venous thromboembolism (VTE) risk. Whether this is due to the medication or the underlying disease, or affects the risk of VTE recurrence, has been difficult to determine. The aim of our present study was to quantify the risk for first and recurrent VTE associated with oral glucocorticoids use, considering the underlying disease. A total of 2547 patients with VTE from the Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis (MEGA) study were linked to the Dutch Pharmaceutical Statistics register. The risk of first VTE during periods of exposure with oral glucocorticoids was estimated by the self-controlled case series method and that of recurrent VTE was examined in a cohort design. The incidence rate ratio (IRR) of first VTE in the period of glucocorticoid treatment was 3·51 [95% confidence interval (CI) 2·55-4·80]. This IRR was 2·53 (95% CI 1·10-5·72) in the week before treatment started, 5·28 (95% CI 2·89-9·53) in the first 7 days of treatment, remained elevated afterwards and decreased to 1·55 (95% CI 0·85-3·12) after 6 months, as compared to unexposed periods. The hazard ratio for recurrence was 2·72 (95% CI 1·64-4·78) in treatment periods as compared with no treatment. The increased risk of VTE associated with oral glucocorticoid treatment is due to a combined effect of the treatment and the underlying disease, remaining high during the first months of prescription.
引用
- Orsi FA, Lijfering WM, Geersing GJ, et al. Glucocorticoid use and risk of first and recurrent venous thromboembolism: self-controlled case-series and cohort study. Br J Haematol. 2021. PMID: 33748963. doi:10.1111/bjh.17388
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。